Nitin Jain Selected Research

Nitin Jain Research Topics

Disease

56	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2024 - 05/2009
52	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2024 - 09/2009
41	Philadelphia Chromosome 04/2024 - 05/2009
34	Neoplasms (Cancer) 02/2024 - 09/2009
34	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 07/2009
19	Leukemia 04/2024 - 01/2009
17	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2023 - 07/2008
14	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2024 - 06/2010
13	Infections 03/2024 - 11/2015
11	Residual Neoplasm 12/2022 - 09/2009
9	Thrombocytopenia (Thrombopenia) 03/2024 - 01/2018
7	Exanthema (Rash) 11/2023 - 11/2015
6	Anemia 04/2024 - 01/2018
6	Chromosome Aberrations (Chromosome Abnormalities) 01/2023 - 09/2009
6	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023 - 04/2016
6	Pathologic Complete Response 07/2020 - 10/2009
5	Neutropenia 03/2024 - 01/2018
5	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 12/2010
5	Hypertension (High Blood Pressure) 01/2023 - 11/2015
5	Acute Promyelocytic Leukemia 01/2022 - 01/2015
5	Lymphoma (Lymphomas) 01/2022 - 10/2009
4	Primary Myelofibrosis (Myelosclerosis) 04/2024 - 02/2010
4	Blast Crisis (Blast Phase) 01/2023 - 05/2009
4	Hemorrhage 01/2023 - 01/2014
4	Disease Progression 01/2021 - 01/2017
4	Cytopenia 01/2020 - 02/2010
4	Ulcerative Colitis 08/2016 - 09/2013
3	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024 - 01/2019
3	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2024 - 05/2013
3	Hypersensitivity (Allergy) 07/2023 - 09/2022
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2023 - 01/2021
3	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023 - 02/2015
3	Pancreatitis 01/2023 - 11/2015
3	Myocardial Infarction 01/2023 - 11/2015
3	Cytokine Release Syndrome 01/2023 - 12/2017
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 01/2014
3	Pleural Effusion (Pleural Effusions) 11/2022 - 01/2018
3	Leukocytosis (Pleocytosis) 01/2022 - 01/2017
3	COVID-19 01/2021 - 01/2020
3	Diarrhea 01/2019 - 01/2018
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016 - 10/2013
2	Pain (Aches) 01/2023 - 01/2013
2	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2023 - 01/2020
2	Multiple Myeloma 01/2023 - 02/2015
2	Hyperbilirubinemia 01/2022 - 11/2017
2	Pneumonia (Pneumonitis) 01/2022 - 01/2018
2	Hyperuricemia 01/2022 - 01/2017

Drug/Important Bio-Agent (IBA)

28	venetoclaxIBA 03/2024 - 01/2018
22	ibrutinibIBA 11/2023 - 08/2013
18	Tyrosine Kinase InhibitorsIBA 12/2023 - 05/2009
17	blinatumomabIBA 01/2024 - 12/2017
16	ponatinibIBA 04/2024 - 11/2015
15	Inotuzumab OzogamicinIBA 05/2024 - 01/2014
11	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2023 - 02/2016
11	Dasatinib (BMS 354825)FDA Link 01/2023 - 12/2016
11	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 03/2015
9	Rituximab (Mabthera)FDA Link 01/2022 - 06/2014
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 06/2014
8	Vincristine (Oncovin)FDA LinkGeneric 10/2021 - 11/2015
7	Imatinib Mesylate (Gleevec)FDA Link 12/2023 - 07/2008
7	Proteins (Proteins, Gene)FDA Link 06/2023 - 09/2009
6	Azacitidine (5 Azacytidine)FDA Link 11/2023 - 01/2020
6	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 11/2023 - 01/2017
6	fludarabineIBA 01/2022 - 06/2014
6	Decitabine FDA Link 01/2021 - 06/2010
5	Cladribine FDA LinkGeneric 11/2023 - 01/2021
5	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2018
5	Transaminases (Aminotransferases)IBA 01/2023 - 11/2017
5	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021 - 02/2016
5	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 02/2016
4	Alanine Transaminase (SGPT)IBA 01/2023 - 11/2015
4	nelarabine (506U78)FDA Link 01/2023 - 01/2018
4	CreatinineIBA 01/2022 - 12/2018
4	Arsenic Trioxide (Trisenox)FDA Link 01/2022 - 01/2017
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 01/2017
4	Lenalidomide (CC 5013)FDA Link 01/2021 - 01/2018
4	CurcuminIBA 08/2016 - 09/2013
3	Immunoconjugates (Immunoconjugate)IBA 05/2024 - 01/2014
3	BilirubinIBA 11/2023 - 12/2018
3	Purine NucleosidesIBA 01/2023 - 11/2017
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 11/2015
3	ruxolitinibIBA 10/2021 - 02/2017
3	Clofarabine (Clolar)FDA Link 01/2021 - 11/2017
3	duvelisibIBA 11/2018 - 05/2017
3	Monoclonal AntibodiesIBA 01/2018 - 10/2009
2	Alkylating AgentsIBA 02/2024 - 07/2009
2	NivolumabIBA 02/2024 - 01/2023
2	snake venom protein C activatorIBA 10/2023 - 01/2021
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	Core Binding Factors (Core-Binding Factor)IBA 01/2022 - 07/2009
2	trametinibIBA 01/2022 - 01/2019
2	Gemtuzumab (Mylotarg)FDA Link 01/2022 - 01/2017

Therapy/Procedure

75	Therapeutics 04/2024 - 01/2009
41	Drug Therapy (Chemotherapy) 01/2024 - 11/2015
7	Stem Cell Transplantation 01/2024 - 05/2013
4	Salvage Therapy 01/2023 - 01/2020
3	Consolidation Chemotherapy 12/2022 - 01/2018
3	Microspheres (Microsphere) 01/2016 - 01/2013
2	Cell Transplantation 01/2022 - 01/2021